101 related articles for article (PubMed ID: 38737681)
1. Potential role of lncRNA LOXL1-AS1 in human cancer development: a narrative review.
Tang M; Rong Y; Liu S; Wu Z; Ma G; Li X; Cai H
Transl Cancer Res; 2024 Apr; 13(4):1997-2011. PubMed ID: 38737681
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
Fu XP; Ji CY; Tang WQ; Yu TT; Luo L
Clin Exp Med; 2024 May; 24(1):93. PubMed ID: 38693424
[TBL] [Abstract][Full Text] [Related]
3. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes.
Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY
J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348
[TBL] [Abstract][Full Text] [Related]
4. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
Wu C; Zhang J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
[TBL] [Abstract][Full Text] [Related]
5. Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma.
Feng Z; Ye Z; Xie J; Chen W; Li W; Xing C
Biol Direct; 2021 Dec; 16(1):24. PubMed ID: 34863279
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
7. Cancers make their own luck: theories of cancer origins.
Jassim A; Rahrmann EP; Simons BD; Gilbertson RJ
Nat Rev Cancer; 2023 Oct; 23(10):710-724. PubMed ID: 37488363
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LOXL1-AS1 promotes proliferation and invasion and inhibits apoptosis in retinoblastoma by regulating the MAPK signaling pathway.
Wu W; Zhang Y; Xu C; Yang H; Liu S; Huang G
Mol Cell Biochem; 2024 Apr; 479(4):1011-1022. PubMed ID: 37273040
[TBL] [Abstract][Full Text] [Related]
9. EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin?
Akhmetkaliyev A; Alibrahim N; Shafiee D; Tulchinsky E
Mol Cancer; 2023 May; 22(1):90. PubMed ID: 37259089
[TBL] [Abstract][Full Text] [Related]
10. Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review.
Al-Tashi Q; Saad MB; Muneer A; Qureshi R; Mirjalili S; Sheshadri A; Le X; Vokes NI; Zhang J; Wu J
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175487
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer.
Huang PS; Wang LY; Wang YW; Tsai MM; Lin TK; Liao CJ; Yeh CT; Lin KH
Cells; 2023 Mar; 12(6):. PubMed ID: 36980210
[TBL] [Abstract][Full Text] [Related]
12. Management of Patients Diagnosed with Endometrial Cancer: Comparison of Guidelines.
Restaino S; Paglietti C; Arcieri M; Biasioli A; Della Martina M; Mariuzzi L; Andreetta C; Titone F; Bogani G; Raimondo D; Perelli F; Buda A; Petrillo M; Greco P; Ercoli A; Fanfani F; Scambia G; Driul L; Vizzielli G;
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831434
[TBL] [Abstract][Full Text] [Related]
13. Targeting ovarian cancer stem cells: a new way out.
Ma H; Tian T; Cui Z
Stem Cell Res Ther; 2023 Feb; 14(1):28. PubMed ID: 36788591
[TBL] [Abstract][Full Text] [Related]
14. Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer.
Liu C; Li X; Huang Q; Zhang M; Lei T; Wang F; Zou W; Huang R; Hu X; Wang C; Zhang X; Sun B; Xing L; Yue J; Yu J
Signal Transduct Target Ther; 2023 Jan; 8(1):44. PubMed ID: 36710358
[TBL] [Abstract][Full Text] [Related]
15. Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks.
Hashemi M; Hasani S; Hajimazdarany S; Ghadyani F; Olyaee Y; Khodadadi M; Ziyarani MF; Dehghanpour A; Salehi H; Kakavand A; Goharrizi MASB; Aref AR; Salimimoghadam S; Akbari ME; Taheriazam A; Hushmandi K; Entezari M
Int J Biol Macromol; 2023 Mar; 232():123377. PubMed ID: 36702226
[TBL] [Abstract][Full Text] [Related]
16. FLVCR1-AS1 and FBXL19-AS1: Two Putative lncRNA Candidates in Multiple Human Cancers.
Sheykhhasan M; Tanzadehpanah H; Ahmadieh Yazdi A; Mahaki H; Seyedebrahimi R; Akbari M; Manoochehri H; Kalhor N; Dama P
Noncoding RNA; 2022 Dec; 9(1):. PubMed ID: 36649030
[TBL] [Abstract][Full Text] [Related]
17. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
